Synergenz BioScience Ltd was formed in 2004 to commercialize discoveries about lung disease susceptibility first made by Dr. Robert P Young in research conducted at the University of Auckland in New Zealand. The Company licenses its core intellectual property and related marketing services in key markets around the world. The Company was originally spun off from Auckland University and backed by the Hong Kong-based Pacific Group Ltd. and its investment partners. Synergenz's research program continues in New Zealand and in collaboration with leading investigators, licensees and commercial partners around the world.Synergenz BioScience, Inc., located in Evanston, Illinois has been established to provide marketing services.
| Website | http://www.synergenz.com |
| Employees | View employees |
| Address | 1718 Sherman Ave Ste 311, Evanston, Illinois 60201, US |
| Phone | +1 312-376-7888 |
| Industry | Charitable Organizations & Foundations, Organizations |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Eppendorf Group, Molecular Devices +32 more (view full list) |
| SIC | SIC Code 839 Companies, SIC Code 83 Companies |
| NAICS | NAICS Code 81321 Companies, NAICS Code 813 Companies, NAICS Code 8132 Companies, NAICS Code 81 Companies, NAICS Code 813212 Companies |
Looking for a particular Synergenz Bioscience Ltd employee's phone or email?
Synergenz Bioscience Ltd is based in Evanston, Illinois.
The NAICS codes for Synergenz Bioscience Ltd are [81321, 813, 8132, 81, 813212].
The SIC codes for Synergenz Bioscience Ltd are [839, 83].